Crossbow Therapeutics

Edit info

Founded: 2021

Location: Cambridge, MA

Employee range: 11 - 50

Clinical stage: RD

Drug types: ONC

Funding: $80M A Jul 2023

Investors: MPM BioImpact, Pfizer Ventures, Polaris Partners, BVF Partners, Eli Lilly, Mirae Asset Venture Investment, Mirae Asset Capital

crossbowtx.com

linkedin.com

About:

The mission of Crossbow Therapeutics is to cure cancer. Their team is developing highly potent and accurate antibody-based therapies to target tumor-specific peptides. They are developing next-generation immunotherapies, called T-Bolt therapies, utilizing T cell receptor-memetic antibodies. Crossbow was founded in 2021 by co-founders Geraldine Paulus, Patrick Baeuerle, and Todd Foley.

Jobs:

Main

Contact: recruit@workinbiotech.com